share_log

EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans

EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans

独家:Ayahuasca Pill 正式上市,Filament 首席执行官讨论未来计划
Benzinga Real-time News ·  2022/12/15 12:51
Part one of a three-part series.
由三部分组成的系列的第一部分。
The first medical-grade drug candidate of the psychedelic ayahuasca is being developed.
迷幻 ayahuasca 的第一个医疗级候选药物正在开发中。
Currently in the form of a pill, the compound was conceived by Vancouver, BC-based natural drug development company Filament Health (OTC:FLHLF).
目前以 a 的形式 丸,该化合物由总部位于不列颠哥伦比亚省温哥华的天然药物开发公司构思 灯丝健康 (场外:FLHLF)。
During the development process, questions arose:
在开发过程中,出现了以下问题:
What exactly constitutes a dose when discussing a drug typically used within religious contexts? What's the need of the drug-induced trip experience (and the typical pre-trip nausea) for obtaining health benefits? How can Filament actually perform drug development tasks in a responsible manner facing ayahuasca's sacramental essence...
在讨论通常在宗教背景下使用的药物时,究竟什么构成剂量? 药物引起的旅行经历(以及典型的旅行前恶心)需要...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发